2cellsbio.com

What It Is

Voredos SRL is a small bioinformatics company registered in Ramillies, Belgium, focusing on immune system–related data, especially large-scale nucleic acid data, antibody repertoires, and phage libraries. Its flagship product, AIRRDB, is described as a database platform for searching known human paratope space, aiming to help researchers quickly retrieve and analyze public human antibody sequence data.

Core Capabilities

Based on the main content, AIRRDB’s core value lies in large-scale antibody sequence similarity search: the platform contains more than 2.1 billion entries from public sources, can perform ultra-fast similarity searches across billions of CDR-H3 sequences, and supports sub-second queries with up to two mismatches per CDR. Its underlying technology is related to Voredos’s patented N-Hamming search method. In addition to its database product, the company also provides B-cell receptor sequencing, custom analysis pipelines, antibody repertoire comparison, and consulting for computational immunology projects.

Pricing and Delivery

The main content does not disclose AIRRDB’s pricing model, trial options, enterprise licensing, payment methods, nor does it specify whether API, SDK, self-hosting, or private deployment are supported. It only mentions that the company’s infrastructure is hosted in the EU and that it collaborates remotely with partners in Europe and North America. Therefore, before commercial procurement, it is necessary to further confirm data access methods, query quotas, compliance terms, and service support.

Pros and Cons

Its strengths are its very clear positioning, targeting high-value problems in antibody discovery and immune repertoire research; its large data scale and prominently described search performance; and a founding team with experience in bioinformatics, immunology, NGS pipelines, and antibody discovery. The downside is that the publicly available materials lean more toward a company introduction and lack the API documentation, integration guidance, data update frequency, quality control process, and deployment options that developers care about, leaving insufficient information to evaluate it as a “developer tool.”

Who It’s For and Access from China

It is better suited for teams working on antibody drug development, vaccine response research, BCR sequencing analysis, and computational immunology, rather than general software developers. Access from China is not mentioned in the main content. The connectivity, speed, and compliance availability of the domain and AIRRDB services in mainland China all require real-world testing; the current assessment is unknown.